Evidence map›Paper›PMID 34704832›Full record

ArticleMicrobiology spectrum2021

An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization.

Nicholas Wohlgemuth, Kendall Whitt, Sean Cherry, Ericka Kirkpatrick Roubidoux, Chun-Yang Lin, Kim J Allison, Ashleigh Gowen, Pamela Freiden, E Kaitlynn Allen, St. Jude Investigative Team, and 12 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 2 institutions in 1 country.

Nicholas WohlgemuthDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Kendall WhittDepartment of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Centergrid.267301.1, Memphis, Tennessee, USA.
Sean CherryDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Ericka Kirkpatrick RoubidouxDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Chun-Yang LinDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Kim J AllisonDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Ashleigh GowenDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Pamela FreidenDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
E Kaitlynn AllenDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
St. Jude Investigative Team,
Aditya H GaurDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Jeremie H EsteppDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Li TangDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Tomi MoriDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Diego R HijanoDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Hana HakimDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Maureen A McGargillDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0000-0002-0916-0372
Florian KrammerDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID 0000-0003-4121-776X
Michael A WhittDepartment of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Centergrid.267301.1, Memphis, Tennessee, USA.
Joshua WolfDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0000-0002-9912-3646
Paul G ThomasDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Stacey Schultz-CherryDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0000-0002-2021-727X
St. Jude Children's Research Hospital · USUniversity of Tennessee Health Science Center · US

Funding

COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: UNIVERSAL INFLUENZA VACCINE RESEARCH75N93019C00051 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KRAMMER, FLORIAN · 2019 to 2025
$105.4M
COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,75N93019C00052 · NIAID · UNIVERSITY OF GEORGIA · PI ROSS, TED · 2019 to 2025
$74.6M
American Lebanese Syrian Associated Charities (ALSAC)American Society of Hematology (ASH) Scholar AwardHHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) HHSN27220140006CJPB FoundationNIAID NIH HHS 75N93019C00051NIAID NIH HHS 75N93019C00052NIAID NIH HHS HHSN272201400008COpen Philanthropy Project 2020-215611 (5384)Private DonorsSteven and Alexandra Cohen Foundation (Steven & Alexandra Cohen Foundation)University of Tennessee Research Foundation
6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 and has since caused a global pandemic resulting in millions of cases and deaths. Diagnostic tools and serological assays are critical for controlling the outbreak, especially assays designed to quantitate neutralizing antibody levels, considered the best correlate of protection. As vaccines become increasingly available, it is important to identify reliable methods for measuring neutralizing antibody responses that correlate with authentic virus neutralization but can be performed outside biosafety level 3 (BSL3) laboratories. While many neutralizing assays using pseudotyped virus have been developed, there have been few studies comparing the different assays to each other as surrogates for authentic virus neutralization. Here, we characterized three enzyme-linked immunosorbent assays (ELISAs) and three pseudotyped vesicular stomatitis virus (VSV) neutralization assays and assessed their concordance with authentic virus neutralization. The most accurate assays for predicting authentic virus neutralization were luciferase- and secreted embryonic alkaline phosphatase (SEAP)-expressing pseudotyped virus neutralizations, followed by green fluorescent protein (GFP)-expressing pseudotyped virus neutralization, and then the ELISAs.

Indexed as

AdultAntibodies, NeutralizingAntibodies, ViralCOVID-19COVID-19 Serological TestingEnzyme-Linked Immunosorbent AssayFemaleHumansMaleMiddle AgedNeutralization TestsProtein DomainsSARS-CoV-2Spike Glycoprotein, CoronavirusVesicular stomatitis Indiana virusVesicular stomatitis New Jersey virusAntibodies, NeutralizingAntibodies, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2immunoassaysneutralizing antibodiesSARS-CoV-2

Identifiers

PMID34704832
PMCPMC8549747
OpenAlexW3208467108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.